Bios Life has raised $25 million in seed funding to develop digital twins for cancer screening, led by Redmile, Vsquared Ventures, and Kindred Capital.
PRIVATEAug 11, 2026
Amount Raised
$25 Million
Round Type
Seed
BostonBiotechnologyHealth CareMedical
Investors
RedmileVsquared VenturesKindred Capital
Description
Bios Life has emerged from stealth mode with $25 million in seed funding, aimed at developing digital twin cancer risk models. The funding round is led by Redmile, Vsquared Ventures, and Kindred Capital, marking the company's first outside funding. A multi-year partnership with Tempus complements its innovative approach to cancer screening. The company's technology seeks to address the significant gaps in access to tailored care for high-risk individuals and cancer survivors.
Company Information
Company
Bios Life
Location
Boston, Massachusetts, United States
About
Bios Life is a healthtech company focused on developing digital twin cancer risk models. Founded by former BioNTech executives, the company aims to provide tailored care for high-risk individuals and cancer survivors. Their platform incorporates clinical, lab, and genetic data to continuously update patient risk profiles. Bios Life has emerged from stealth with a significant funding round and partnerships to enhance its technology and services.
Fundz sees it the moment Bios Life raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonBiotechnologyHealth CareMedical